KEGG   PATHWAY: ocu04936
Entry
ocu04936                    Pathway                                
Name
Alcoholic liver disease - Oryctolagus cuniculus (rabbit)
Description
Alcoholic liver disease (ALD) refers to the damages to the liver and its functions due to alcohol overconsumption. It ranges from simple steatosis to steatohepatitis, cirrhosis, and even hepatocellular carcinoma. Alcohol consumption promotes liver inflammation by increasing the translocation of gut-derived endotoxins to the portal circulation and activating Kupffer cells to produce TNF-alpha through the LPS/Toll like receptor (TLR) 4 pathways. TNF-alpha induces hepatocellular damage. When alcohol intake is chronic and heavy, steatosis is caused via generation of acetaldehyde, reactive oxygen species (ROS) and ER stress. ROS inhibits key hepatic transcriptional regulators such as AMP-activated kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPAR-alpha), which are responsible for fatty acid oxidation and export via ACC and CPT-1. The blockade of AMPK also leads to overexpression of SREBP-1, resulting in an increase of de novo lipogenesis. Moreover, excessive intracellular ROS production induced by ethanol and its metabolite have a critical role in ethanol-induced apoptosis, which may be the critical process in the exacerbation of ALD. It is inferred that the apoptotic signal derived from ROS that was produced by NOX, is mainly transduced through the JNK and p38 MAPK pathways.
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
ocu04936  Alcoholic liver disease
ocu04936

Disease
H02516  Alcoholic liver disease
Organism
Oryctolagus cuniculus (rabbit) [GN:ocu]
Gene
100008609  FAS; tumor necrosis factor receptor superfamily member 6 precursor [KO:K04390]
100008733  IL6; interleukin-6 precursor [KO:K05405]
100008840  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
100008983  CD14; monocyte differentiation antigen CD14 precursor [KO:K04391]
100008990  IL1B; interleukin-1 beta precursor [KO:K04519]
100009027  ADIPOQ; adiponectin precursor [KO:K07296]
100009088  TNF; tumor necrosis factor precursor [KO:K03156]
100009121  C3; complement C3 alpha chain [KO:K03990]
100009124  LBP; lipopolysaccharide-binding protein precursor [KO:K05399]
100009129  CXCL8; interleukin-8 precursor [KO:K10030]
100009245  GRO-A; GRO alpha protein precursor [KO:K05505]
100009283  ADH1A; alcohol dehydrogenase 1 [KO:K13951] [EC:1.1.1.1]
100009307  ADH5; alcohol dehydrogenase class-3 [KO:K00121] [EC:1.1.1.284 1.1.1.1]
100009497  TLR4; toll-like receptor 4 [KO:K10160]
100009589  LY96; lymphocyte antigen 96 precursor [KO:K05400]
100125985  [KO:K02105]
100144331  [KO:K07297]
100144332  [KO:K07297]
100327260  ADH2-1; alcohol dehydrogenase class-2 isozyme 1 [KO:K13980] [EC:1.1.1.1]
100328583  GRO-B; permeability factor 2 [KO:K05505]
100328905  IKBKG; NF-kappa-B essential modulator [KO:K07210]
100337888  [KO:K03171]
100337999  [KO:K04440] [EC:2.7.11.24]
100338228  [KO:K01578] [EC:4.1.1.9]
100338450  [KO:K00232] [EC:1.3.3.6]
100338523  [KO:K00128] [EC:1.2.1.3]
100338708  [KO:K05403]
100338784  [KO:K00128] [EC:1.2.1.3]
100339216  [KO:K02620]
100339322  [KO:K05489]
100339362  [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
100339678  [KO:K12793]
100339697  [KO:K21423] [EC:1.6.3.-]
100339794  [KO:K00128] [EC:1.2.1.3]
100339953  [KO:K04432] [EC:2.7.12.2]
100340412  [KO:K07199]
100340471  [KO:K04490]
100340498  [KO:K04426] [EC:2.7.11.25]
100340670  [KO:K07198] [EC:2.7.11.31]
100340811  [KO:K04729]
100341327  [KO:K19524] [EC:2.3.1.21]
100341605  [KO:K04733] [EC:2.7.11.1]
100341695  [KO:K04441] [EC:2.7.11.24]
100342249  [KO:K04404]
100342322  [KO:K07415] [EC:1.14.14.-]
100342572  [KO:K07415] [EC:1.14.14.-]
100342664  [KO:K04440] [EC:2.7.11.24]
100342852  [KO:K04456] [EC:2.7.11.1]
100342931  [KO:K05415]
100343190  [KO:K03175] [EC:2.3.2.27]
100343571  [KO:K04427] [EC:2.7.11.25]
100343573  [KO:K09408]
100343992  [KO:K13952] [EC:1.1.1.1]
100344073  [KO:K04389]
100344161  [KO:K04441] [EC:2.7.11.24]
100344302  [KO:K14085] [EC:1.2.1.31 1.2.1.8 1.2.1.3]
100344498  [KO:K00507] [EC:1.14.19.1]
100344852  [KO:K04430] [EC:2.7.12.2]
100345521  ADH2-2; alcohol dehydrogenase class-2 isozyme 2 [KO:K13980] [EC:1.1.1.1]
100346046  [KO:K00507] [EC:1.14.19.1]
100346106  [KO:K03158]
100346262  [KO:K15728] [EC:3.1.3.4]
100346306  [KO:K00507] [EC:1.14.19.1]
100346561  [KO:K00507] [EC:1.14.19.1]
100346654  [KO:K09479] [EC:1.3.8.9]
100346929  [KO:K04440] [EC:2.7.11.24]
100347504  [KO:K00249] [EC:1.3.8.7]
100348186  [KO:K15728] [EC:3.1.3.4]
100348321  [KO:K15728] [EC:3.1.3.4]
100348477  [KO:K04398] [EC:3.4.22.61]
100348780  [KO:K07199]
100348842  [KO:K03083] [EC:2.7.11.26]
100349007  [KO:K05406]
100349219  [KO:K07202]
100349271  [KO:K11411] [EC:2.3.1.286]
100349426  [KO:K02580]
100349628  [KO:K00128] [EC:1.2.1.3]
100350311  [KO:K08765] [EC:2.3.1.21]
100350539  [KO:K05166]
100350614  [KO:K04441] [EC:2.7.11.24]
100350689  [KO:K07359] [EC:2.7.11.17]
100350716  [KO:K08765] [EC:2.3.1.21]
100351032  [KO:K04466] [EC:2.7.11.25]
100351157  [KO:K04009]
100351329  [KO:K12897]
100352581  [KO:K07200]
100352691  [KO:K04492]
100352965  [KO:K02861] [EC:2.7.11.1]
100352978  [KO:K04010]
100353138  [KO:K19523] [EC:2.3.1.21]
100353180  [KO:K07200]
100353390  [KO:K05414]
100353706  [KO:K04456] [EC:2.7.11.1]
100353793  [KO:K12897]
100354455  [KO:K07211] [EC:2.7.11.10]
100354540  [KO:K00149] [EC:1.2.1.47 1.2.1.3]
100354654  [KO:K05414]
100354672  [KO:K08750]
100354743  [KO:K04730] [EC:2.7.11.1]
100354852  [KO:K05425]
100355230  [KO:K04433] [EC:2.7.12.2]
100355553  [KO:K01332] [EC:3.4.21.43]
100355669  [KO:K05414]
100355862  [KO:K05164]
100355888  [KO:K04467] [EC:2.7.11.10]
100355912  [KO:K05414]
100355970  [KO:K11262] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
100356401  [KO:K07209] [EC:2.7.11.10]
100356419  [KO:K05414]
100356422  [KO:K07294]
100356542  [KO:K07200]
100356678  [KO:K05414]
100356976  [KO:K03989]
100357194  [KO:K05414]
100357341  [KO:K04734]
100357419  [KO:K00507] [EC:1.14.19.1]
100357708  [KO:K05414]
100358166  [KO:K07198] [EC:2.7.11.31]
100358246  [KO:K04403]
100358378  [KO:K04491]
100358471  [KO:K07201]
100358771  [KO:K05410] [EC:2.7.11.10]
100359083  [KO:K03174]
103345313  [KO:K04431] [EC:2.7.12.2]
103346035  [KO:K04441] [EC:2.7.11.24]
103346501  [KO:K07197]
103346571  [KO:K05411]
103346593  [KO:K08765] [EC:2.3.1.21]
103352022  [KO:K03994]
103352041  [KO:K03994]
108175374  [KO:K05399]
127482788  [KO:K03987]
127485184  [KO:K04735]
127486116  [KO:K04456] [EC:2.7.11.1]
127486773  [KO:K00128] [EC:1.2.1.3]
127488422  [KO:K07359] [EC:2.7.11.17]
127488891  [KO:K03989]
127488893  [KO:K01332] [EC:3.4.21.43]
127490351  [KO:K15728] [EC:3.1.3.4]
Compound
C00003  NAD+
C00005  NADPH
C00006  NADP+
C00024  Acetyl-CoA
C00033  Acetate
C00040  Acyl-CoA
C00076  Calcium cation
C00083  Malonyl-CoA
C00084  Acetaldehyde
C00469  Ethanol
C22381  Reactive oxygen species
Reference
  Authors
Louvet A, Mathurin P
  Title
Alcoholic liver disease: mechanisms of injury and targeted treatment.
  Journal
Nat Rev Gastroenterol Hepatol 12:231-42 (2015)
DOI:10.1038/nrgastro.2015.35
Reference
  Authors
Gao B, Bataller R
  Title
Alcoholic liver disease: pathogenesis and new therapeutic targets.
  Journal
Gastroenterology 141:1572-85 (2011)
DOI:10.1053/j.gastro.2011.09.002
Reference
  Authors
Magdaleno F, Blajszczak CC, Nieto N
  Title
Key Events Participating in the Pathogenesis of Alcoholic Liver Disease.
  Journal
Biomolecules 7:9 (2017)
DOI:10.3390/biom7010009
Reference
  Authors
Lucey MR, Mathurin P, Morgan TR
  Title
Alcoholic hepatitis.
  Journal
N Engl J Med 360:2758-69 (2009)
DOI:10.1056/NEJMra0805786
Reference
  Authors
Nagy LE, Ding WX, Cresci G, Saikia P, Shah VH
  Title
Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.
  Journal
Gastroenterology 150:1756-68 (2016)
DOI:10.1053/j.gastro.2016.02.035
Reference
  Authors
Fujii H, Kawada N
  Title
Fibrogenesis in alcoholic liver disease.
  Journal
World J Gastroenterol 20:8048-54 (2014)
DOI:10.3748/wjg.v20.i25.8048
Reference
  Authors
Kim MS, Ong M, Qu X
  Title
Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?
  Journal
World J Gastroenterol 22:8-23 (2016)
DOI:10.3748/wjg.v22.i1.8
Reference
  Authors
You M, Crabb DW
  Title
Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.
  Journal
Am J Physiol Gastrointest Liver Physiol 287:G1-6 (2004)
DOI:10.1152/ajpgi.00056.2004
Reference
  Authors
Nagy LE
  Title
The Role of Innate Immunity in Alcoholic Liver Disease.
  Journal
Alcohol Res 37:237-50 (2015)
Reference
  Authors
Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, Nagy L, Szabo G, Zakhari S
  Title
Innate immunity in alcoholic liver disease.
  Journal
Am J Physiol Gastrointest Liver Physiol 300:G516-25 (2011)
DOI:10.1152/ajpgi.00537.2010
Reference
  Authors
Wang HJ, Gao B, Zakhari S, Nagy LE
  Title
Inflammation in alcoholic liver disease.
  Journal
Annu Rev Nutr 32:343-68 (2012)
DOI:10.1146/annurev-nutr-072610-145138
Reference
  Authors
McCullough RL, McMullen MR, Sheehan MM, Poulsen KL, Roychowdhury S, Chiang DJ, Pritchard MT, Caballeria J, Nagy LE
  Title
Complement Factor D protects mice from ethanol-induced inflammation and liver injury.
  Journal
Am J Physiol Gastrointest Liver Physiol 315:G66-G79 (2018)
DOI:10.1152/ajpgi.00334.2017
Reference
  Authors
Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, Noguchi R, Yoshiji H, Fujimoto M, Fukui H
  Title
The effect of inflammatory cytokines in alcoholic liver disease.
  Journal
Mediators Inflamm 2013:495156 (2013)
DOI:10.1155/2013/495156
Reference
  Authors
Szabo G, Bala S
  Title
Alcoholic liver disease and the gut-liver axis.
  Journal
World J Gastroenterol 16:1321-9 (2010)
DOI:10.3748/wjg.v16.i11.1321
Reference
  Authors
Kawaratani H, Moriya K, Namisaki T, Uejima M, Kitade M, Takeda K, Okura Y, Kaji K, Takaya H, Nishimura N, Sato S, Sawada Y, Seki K, Kubo T, Mitoro A, Yamao J, Yoshiji H
  Title
Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).
  Journal
Int J Mol Med 40:263-270 (2017)
DOI:10.3892/ijmm.2017.3015
Reference
  Authors
Roh YS, Seki E
  Title
Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.
  Journal
J Gastroenterol Hepatol 28 Suppl 1:38-42 (2013)
DOI:10.1111/jgh.12019
Reference
  Authors
Rogers CQ, Ajmo JM, You M
  Title
Adiponectin and alcoholic fatty liver disease.
  Journal
IUBMB Life 60:790-7 (2008)
DOI:10.1002/iub.124
Reference
  Authors
You M, Jogasuria A, Lee K, Wu J, Zhang Y, Lee YK, Sadana P
  Title
Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1.
  Journal
Curr Mol Pharmacol 10:226-236 (2017)
DOI:10.2174/1874467208666150817112109
Reference
  Authors
You M, Jogasuria A, Taylor C, Wu J
  Title
Sirtuin 1 signaling and alcoholic fatty liver disease.
  Journal
Hepatobiliary Surg Nutr 4:88-100 (2015)
DOI:10.3978/j.issn.2304-3881.2014.12.06
Reference
  Authors
Ren R, Wang Z, Wu M, Wang H
  Title
Emerging Roles of SIRT1 in Alcoholic Liver Disease.
  Journal
Int J Biol Sci 16:3174-3183 (2020)
DOI:10.7150/ijbs.49535
Reference
  Authors
Purohit V, Gao B, Song BJ
  Title
Molecular mechanisms of alcoholic fatty liver.
  Journal
Alcohol Clin Exp Res 33:191-205 (2009)
DOI:10.1111/j.1530-0277.2008.00827.x
Reference
  Authors
Hyun J, Han J, Lee C, Yoon M, Jung Y
  Title
Pathophysiological Aspects of Alcohol Metabolism in the Liver.
  Journal
Int J Mol Sci 22:5717 (2021)
DOI:10.3390/ijms22115717
Reference
  Authors
Combs TP, Marliss EB
  Title
Adiponectin signaling in the liver.
  Journal
Rev Endocr Metab Disord 15:137-47 (2014)
DOI:10.1007/s11154-013-9280-6
Reference
  Authors
Ceni E, Mello T, Galli A
  Title
Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
  Journal
World J Gastroenterol 20:17756-72 (2014)
DOI:10.3748/wjg.v20.i47.17756
Reference
  Authors
Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T
  Title
Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease.
  Journal
Int J Mol Sci 20:E2712 (2019)
DOI:10.3390/ijms20112712
Reference
  Authors
Ohashi K, Pimienta M, Seki E
  Title
Alcoholic liver disease: A current molecular and clinical perspective.
  Journal
Liver Res 2:161-172 (2018)
DOI:10.1016/j.livres.2018.11.002
Reference
  Authors
You M, Arteel GE
  Title
Effect of ethanol on lipid metabolism.
  Journal
J Hepatol 70:237-248 (2019)
DOI:10.1016/j.jhep.2018.10.037
Reference
  Authors
Bi L, Jiang Z, Zhou J
  Title
The role of lipin-1 in the pathogenesis of alcoholic fatty liver.
  Journal
Alcohol Alcohol 50:146-51 (2015)
DOI:10.1093/alcalc/agu102
Reference
  Authors
Ali H, Assiri MA, Shearn CT, Fritz KS
  Title
Lipid peroxidation derived reactive aldehydes in alcoholic liver disease.
  Journal
Curr Opin Toxicol 13:110-117 (2019)
DOI:10.1016/j.cotox.2018.10.003
Reference
  Authors
Yin H, Hu M, Liang X, Ajmo JM, Li X, Bataller R, Odena G, Stevens SM Jr, You M
  Title
Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.
  Journal
Gastroenterology 146:801-11 (2014)
DOI:10.1053/j.gastro.2013.11.008
Reference
  Authors
Stickel F, Hampe J
  Title
Genetic determinants of alcoholic liver disease.
  Journal
Gut 61:150-9 (2012)
DOI:10.1136/gutjnl-2011-301239
Reference
  Authors
Yang CF, Zhong YJ, Ma Z, Li L, Shi L, Chen L, Li C, Wu D, Chen Q, Li YW
  Title
NOX4/ROS mediate ethanolinduced apoptosis via MAPK signal pathway in L02 cells.
  Journal
Int J Mol Med 41:2306-2316 (2018)
DOI:10.3892/ijmm.2018.3390
Related
pathway
ocu00061  Fatty acid biosynthesis
ocu00071  Fatty acid degradation
ocu01040  Biosynthesis of unsaturated fatty acids
ocu03040  Spliceosome
ocu04010  MAPK signaling pathway
ocu04064  NF-kappa B signaling pathway
ocu04152  AMPK signaling pathway
ocu04210  Apoptosis
ocu04310  Wnt signaling pathway
ocu04610  Complement and coagulation cascades
ocu04620  Toll-like receptor signaling pathway
ocu04657  IL-17 signaling pathway
ocu04668  TNF signaling pathway
ocu04920  Adipocytokine signaling pathway
ocu05034  Alcoholism
ocu05225  Hepatocellular carcinoma
KO pathway
ko04936   

DBGET integrated database retrieval system